---
title: Femtosecond Laser-Assisted Keratoplasty
nct_id: NCT01695811
overall_status: COMPLETED
sponsor: University of Michigan
study_type: OBSERVATIONAL
primary_condition: Keratoconus
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT01695811.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT01695811"
ct_last_update_post_date: 2015-01-21
last_seen_at: "2026-05-12T06:33:53.513Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Femtosecond Laser-Assisted Keratoplasty

**NCT ID:** [NCT01695811](https://clinicaltrials.gov/study/NCT01695811)

## Key Facts

- **Status:** COMPLETED
- **Study Type:** OBSERVATIONAL
- **Target Enrollment:** 24
- **Lead Sponsor:** University of Michigan
- **Conditions:** Keratoconus
- **Start Date:** 2007-11
- **Completion Date:** 2013-12
- **CT.gov Last Update:** 2015-01-21

## Brief Summary

The purpose of this study will be to determine optimal surgical technique for performing FLAK including laser parameters, keratoplasty shape and suture technique in order to standardize surgical technique and to collect safety and efficacy data. This will be compared to data of patients with full thickness PKP to measure visual outcomes, refraction, astigmatism, surgical methods and wound healing.

## Detailed Description

FLAK Instrument: The Femtosecond Laser (IntraLase Corporation, Irvine, CA) is a focusable infrared laser, similar to the more familiar neodymium-yttrium-aluminum-garnet (YAG) laser, but uses shorter pulses in the hundred-femtosecond (100 X 10-15 seconds) duration range. There is minimal postoperative inflammation and collateral tissue damage.

Subjects: We will be enrolling subjects 18 years or older that need keratoplasty based on clinical findings. Subjects will be enrolled regardless of race or gender on a first come first serve basis. Subjects will be recruited from the physicians own clinic.

PKP Subjects: We will do a retrospective chart review on subjects who have undergone traditional PKP. FLAK eyes will be age and gender matched to these PKP eyes to compare visual outcomes, wound healing and complications.

## Eligibility

- **Minimum age:** 18 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

1. Corneal opacification.
2. Reduced ETDRS-measured, best corrected, distance visual acuity to 20/40 or worse.
3. Ability to participate in follow-up visits..

Exclusion Criteria:

1. Corneal opacification adequately dense to obscure visualization of iris.
2. ETDRS-measured, best-corrected, distance visual acuity of 20/30 or better.
3. Corneal thickness greater than 1200 µm at the 9 mm peripheral zone.
4. Severe corneal thinning including descemetocoele with impending corneal rupture.
5. Prior PKP or incisional surgery that may provide a potential space into which the gas produced by the procedure can escape.
6. Poor visual potential in the non-study eye (VA of 20/100 or less, without potential for improvement by the examining ophthalmologist's judgment).
7. History of glaucoma, including steroid response rise in intraocular pressure.
8. Active intraocular inflammation or infection.
9. Age 18 or younger (consideration will be given to an upper age limit).
10. Unable to return for scheduled follow-up examinations.
11. Other medical condition(s) that will likely prevent long term follow-up.
```

## Arms

- **FLAK** — FLAK
- **PKP** — Retrospective

## Primary Outcomes

- **Surgical outcomes** _(time frame: 1 day, 1 week, 1, 3, 6, 12, 18 and 24 months)_ — Wound healing, surgical complications, visual function and endothelial layer assessment

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT01695811.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT01695811*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*